- Report
- May 2025
- 50 Pages
Global
From €2453EUR$2,650USD£2,063GBP
Urofollitropin is a drug used to treat endocrine and metabolic disorders. It is a recombinant form of human follicle-stimulating hormone (FSH) and is used to treat infertility in women. It is also used to stimulate the production of sperm in men with hypogonadotropic hypogonadism. Urofollitropin is administered by subcutaneous injection and is available in both powder and liquid forms.
Urofollitropin is used to stimulate the growth of ovarian follicles in women with infertility. It is also used to induce ovulation in women with polycystic ovary syndrome (PCOS). In men, it is used to stimulate the production of sperm in those with hypogonadotropic hypogonadism.
Urofollitropin is a widely used drug in the treatment of endocrine and metabolic disorders. It is available in many countries and is manufactured by several companies, including Merck, Ferring Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more